Indian Billionaire Dilip Shanghvi’s Sun Pharma To Buy U.S. Cancer Drug Maker For $355 Million
Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...
Sun Pharmaceutical Industries advances Monday, outperforms competitors
Sun Pharmaceutical Industries Ltd. closed 12.97% below its 52-week high of 1,960.20 rupees, which the company achieved on ...
Fierce Pharma3d
Dr. Reddy’s, Sun Pharma and Zydus issue US recalls, citing failed specs and labeling issues
The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...
Sun Pharmaceutical Industries rises Tuesday, outperforms market
Sun Pharmaceutical Industries Ltd. closed 10.79% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.
India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million
India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics, a U.S.-based immunotherapy and ...
Devdiscourse4d
Sun Pharma and Zydus Initiate Major US Recalls Amid Manufacturing Concerns
Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...
Fierce Pharma10d
On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. | Three ...
GlobalData on MSN10d
Sun Pharma agrees to acquire Checkpoint Therapeutics
Sun Pharmaceutical Industries has agreed to acquire Checkpoint Therapeutics, a company specialising in immunotherapy and ...
Sun Pharma Share Price Live Updates: Sun Pharma's six-month beta reflects stability
Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...
Analytics Insight13d
Sun Pharma Stock: Is the 28.72% Potential Upside Realistic?
Sun Pharma is a top-ranked Indian pharmaceutical firm. The company’s stock has been continuously in the news lately for ...
The Free Press Journal8d
Sun Pharma Shares Soar After ₹3,000 Crore Acquisition Of US-Based Biotech Company
Chairman & Managing Director of Sun Pharma, said, "Combining UNLOXCYT, an FDAapproved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma, with Sun Pharma’s global presence means ...